Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000125185 | SCV000168626 | benign | not specified | 2014-02-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000727524 | SCV000709451 | uncertain significance | not provided | 2017-06-27 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084572 | SCV001007193 | benign | Epilepsy, childhood absence 2; Febrile seizures, familial, 8 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002415614 | SCV002678626 | benign | Inborn genetic diseases | 2020-06-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000727524 | SCV004011639 | likely benign | not provided | 2023-05-01 | criteria provided, single submitter | clinical testing | GABRG2: BP4, BP7 |